• T: +44 (0) 1869 222 490
  • E: info@mtechaccess.co.uk
  • News
Mtech Access
  • Services
    • Global Market Access and Pricing
    • Global Value Dossiers
      • Global Value Platform
    • Strategic UK Market Access
    • HEOR
    • Health Economics
    • Systematic Literature Review & Network Meta-Analysis
    • HTA Support
    • Customer Communication
      • Budget Impact Models
      • eDetail Solutions and Interactive Visual Aids
      • Data Visualisation
    • Education & Training
  • Digital
    • Digital Capabilities
      • Budget Impact Models
      • Data Visualisation
      • eDetail Solutions and Interactive Visual Aids
      • Global Value Platform
      • Digital Video Library
    • Veeva Partnership
    • Demo centre
  • About
    • Team
    • Brochures
    • Testimonials
    • Case Studies
    • Pharma Market Access
    • Medical Device Market Access
  • Careers
  • News
  • Contact
Press enter to begin your search
  • Services
    • Global Market Access and Pricing
    • Global Value Dossiers
      • Global Value Platform
    • Strategic UK Market Access
    • HEOR
    • Health Economics
    • Systematic Literature Review & Network Meta-Analysis
    • HTA Support
    • Customer Communication
      • Budget Impact Models
      • eDetail Solutions and Interactive Visual Aids
      • Data Visualisation
    • Education & Training
  • Digital
    • Digital Capabilities
      • Budget Impact Models
      • Data Visualisation
      • eDetail Solutions and Interactive Visual Aids
      • Global Value Platform
      • Digital Video Library
    • Veeva Partnership
    • Demo centre
  • About
    • Team
    • Brochures
    • Testimonials
    • Case Studies
    • Pharma Market Access
    • Medical Device Market Access
  • Careers
  • News
  • Contact
20/01/2025
0
what does HEOR really mean in 2025

What does HEOR really mean in 2025?

By | Evidence, Health Economics, Systematic Review, MedTech, Pharma, HTA

Global healthcare faces growing pressures. We explore how HEOR is evolving in 2025 to deliver value, meet payer needs, and support market access decisions.

Read More
12/12/2024
0
HTA decision-making at ISPOR Europe

Insights into HTA decision-making from ISPOR Europe

By Will Battershill | Health Economics, Evidence, ISPOR, Pharma, HTA

Will Battershill and Hollie Wheat from Delta Hat discuss key insights into HTA decision-making from ISPOR Europe. Will explores the hot topic of incorporating patient and carer perspectives into decision-making, whilst Hollie dives into the use of surrogate endpoint evaluation in HTA decision-making.

Read More
09/12/2024
0
Health economics training unpacked: A conversation with the trainers cover

Health economics training unpacked: A conversation with the trainers

By Hannah Baker | Evidence, Health Economics, Education & Training

Discover our tailored health economics training for Pharma and Medtech teams. Delivered by experts, it combines practical insights with real-world experience.

Read More
04/12/2024
0
4

Challenges for orphan medicines entering the European market – Part 4: Operational challenges

By Mtech Team | Global Market Access, Pharma | 2 Comments
In this four-part series, we will explore the various challenges facing orphan medicines entering the European market and suggest solutions that can help improve patient access. In the final part...
Read More
04/12/2024
8
4 roadblocks facing orphan medicines seeking to achieve market access in Europe - Economic evidence development

Challenges for orphan medicines entering the European market – Part 3: Economic evidence development

By Mtech Team | Evidence, Global Market Access, Health Economics, Pharma | 3 Comments
In this four-part series, we will explore the various challenges facing orphan medicines entering the European market and offer solutions that can help improve patient access. In Part 3 of...
Read More
04/12/2024
15
4 roadblocks facing orphan medicines seeking to achieve market access in Europe - Part 2 Clinical evidence development. From Mtech Access

Challenges for orphan medicines entering the European market – Part 2: Clinical evidence development

By Mtech Team | Evidence, Global Market Access, Pharma | 2 Comments
In this four-part series, we will explore the various challenges facing orphan medicines entering the European market and offer solutions that can help improve patient access. In Part 2 of...
Read More
04/12/2024
2
4 roadblocks facing orphan medicines seeking to achieve market access in Europe - disease knowledge and awareness

Challenges for orphan medicines entering the European market – Part 1: Disease knowledge and awareness

By Mtech Team | Pharma, Global Market Access | 3 Comments
In this four-part series, we will explore the various challenges facing orphan medicines entering the European market and offer solutions to help improve patient access. In Part 1, we will...
Read More
02/12/2024
0
FAQs on systematic literature reviews and network meta-analyses in healthcare

FAQs about systematic literature reviews and network meta-analyses in healthcare

By Shona Lang | Evidence, Meta-analysis, Systematic Review, HTA

Are you unsure about some of the terminology used by specialists who are preparing your evidence dossier? Here our experts answer some of the most frequently asked questions about systematic literature reviews and network meta-analysis.

Read More
13/11/2024
0
EU Joint Clinical Assessment (JCA) – implications for Pharma and Medtech cover

EU Joint Clinical Assessment (JCA) – Implications for Pharma and Medtech

By Samantha Gillard | News, Evidence, Global Market Access, Systematic Review, MedTech, Medical Writing, Pharma, HTA

What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?

Read More
13/11/2024
0
Insights and reflections from our transforming healthcare symposium cover

Insights and reflections from our transforming healthcare symposium

By Phil Richardson | Value Communications & Digital, Pharma, MedTech, NHS Insights, Events & Conferences

Discover how our symposium brought NHS and industry together to discuss the future of healthcare. We focused on innovation, collaboration, and transformation.

Read More
« Previous
NextPrevious »

Insights Newsletter

Sign up for our newsletter to get our latest insights in market access, HEOR and healthcare direct to your inbox.

    Recent Posts

    • Transforming global market access: Smarter resource management with local affiliates – a live webinar
    • Live Q&A: Beyond NHS England – Navigating changes at NHSE and DHSC
    • Live Q&A: Beyond NHS England – Restructuring and its implications for Pharma and Medtech

    Categories

    • Events & Conferences
    • Education & Training
    • Technical webinars
    • NHS Whispers
    • Global Whispers
    • Innovation
    • HTA
    • Pharma
    • Medical Writing
    • Value Communications & Digital
    • Webinars & Podcasts
    • MedTech
    • News
    • Connected Insights
    • ISPOR
    • Systematic Review
    • Health Economics
    • NHS Insights
    • Global Market Access
    • Careers
    • Meta-analysis
    • Evidence
    • Veeva
    Ready to start your project? Get in touch

    Company Information

    Mtech Access Limited
    (No. 09875447)

    Registed Address

    2nd Floor
    Rowood House
    Murdock Road
    Bicester
    United Kingdom
    OX26 4PP

    Cookie Consent Settings

    Contact Information

    T: +44 (0) 1869 222 490
    E: info@mtechaccess.co.uk

    A member of the Mtech team will contact you as soon as possible.

    Powered by

    Petauri

    Office Hours (GMT)

    Monday 09:00 – 18:00
    Tuesday 09:00 – 18:00
    Wednesday 09:00 – 18:00
    Thursday 09:00 – 18:00
    Friday 09:00 – 18:00
    Saturday Closed
    Sunday Closed

    Mtech Demo Portal

    As an example of our capabilities please feel free to evaluate our interactive iPad budget impact model demonstration tool.

    Demo portal

    © 2025 Mtech Access. All rights reserved. Privacy policy. Cookie Settings. Sitemap